Skip to main content
Erschienen in: Neurological Sciences 1/2012

01.05.2012 | FICEF SYMPOSIUM: FROM FOOD TO MIGRAINE AND BACK

Is migraine a risk factor for the occurrence of eating disorders? Prevalence and biochemical evidences

verfasst von: Giovanni D’Andrea, Roberto Ostuzzi, Andrea Bolner, Davide Colavito, Alberta Leon

Erschienen in: Neurological Sciences | Sonderheft 1/2012

Einloggen, um Zugang zu erhalten

Abstract

The eating disorders (ED), anorexia nervosa (AN) and bulimia nervosa (BN), are severe psychiatric and somatic conditions occurring mainly in young woman. Although the aetiology is largely unknown, same evidences suggest that biological and psychological factors play a relevant role in the pathogenesis, along with monoamine, indole and same hypothalamic hormonal dysfunctions. Migraine is characterized by similar metabolic and psychological anomalies suggesting that a possible relationship exists between the two pathological conditions. To understand the possible relationship between migraine and ED, we have investigated the prevalence of migraine and the other primary headaches in a large group of AN and BN patients. In addition, we have studied the role of tyrosine metabolism in the same group of AN and BN young woman sufferers. In particular, we measured plasma levels of elusive amines: tyramine (Tyr) and octopamine (Oct) and catecholamines: noradrenalin (NE), dopamine (DA). The results of this study show that the prevalence of migraine in the woman affected by ED is very high (<75 %). The levels of Tyr and DA were higher and levels of NE were lower in the ED patients in respect to the control subjects. These biochemical findings suggest that abnormalities of limbic and hypothalamic circuitries play a role in the pathogenesis of ED. The very high prevalence of migraine in our group of ED sufferers and the biochemical profile of migraine, similar to that of ED patients shown in this study, suggest that migraine may constitute a risk factor for the occurrence of ED in young females. This hypothesis is supported by the onset of migraine attacks that initiated, in the majority of the patients, before the occurrence of ED symptoms.
Literatur
1.
Zurück zum Zitat Bravander T, Bryant-Waugh R, Herzog D et al (2007) Classification of child and adolescent eating disturbances. Workgroup for classification of Eating Disorders in Children and Adolescents (WCEDCA). Int J Eat Disord Nov 40(Suppl):S117–S122 Bravander T, Bryant-Waugh R, Herzog D et al (2007) Classification of child and adolescent eating disturbances. Workgroup for classification of Eating Disorders in Children and Adolescents (WCEDCA). Int J Eat Disord Nov 40(Suppl):S117–S122
2.
Zurück zum Zitat Management of Eating Disorders (2006) RTI-UNIC Evidence Based Practice Center, Research Triangle Park, NC. AHRQ Publication N 06-E010 April Management of Eating Disorders (2006) RTI-UNIC Evidence Based Practice Center, Research Triangle Park, NC. AHRQ Publication N 06-E010 April
3.
Zurück zum Zitat Avraham Y, Hao S, Mendelson S, Berry EM (2001) Tyrosine improves appetite, cognition, and exercise tolerance in activity anorexia. Med Sci Sports Exerc 2104–2210 Avraham Y, Hao S, Mendelson S, Berry EM (2001) Tyrosine improves appetite, cognition, and exercise tolerance in activity anorexia. Med Sci Sports Exerc 2104–2210
4.
Zurück zum Zitat Gross HA, Raymond Lake C, Hebert MH, Ziegler MG, Kopin IJ et al (1979) Catecholamine metabolism in primary anorexia nervosa. J Cin Endocrinol Metab 49:805–809CrossRef Gross HA, Raymond Lake C, Hebert MH, Ziegler MG, Kopin IJ et al (1979) Catecholamine metabolism in primary anorexia nervosa. J Cin Endocrinol Metab 49:805–809CrossRef
5.
Zurück zum Zitat Guido KF, Bailer FU, Shannan H, Wagner A, Kaye WH (2004) Neuroimaging studies in eating disorders. CNS Spectrum 9(7):539–548 Guido KF, Bailer FU, Shannan H, Wagner A, Kaye WH (2004) Neuroimaging studies in eating disorders. CNS Spectrum 9(7):539–548
6.
Zurück zum Zitat D’Andrea G, Leon A (2010) Pathogensis of migraine: from neurotransmitters to neuromodulators and beyond. Neurol Sci 3(Suppl 1):S1–S7CrossRef D’Andrea G, Leon A (2010) Pathogensis of migraine: from neurotransmitters to neuromodulators and beyond. Neurol Sci 3(Suppl 1):S1–S7CrossRef
7.
Zurück zum Zitat D’Andrea G, Granella F, Leone M, Perini F, Carruggio A, Bussone G (2006) Abnormal platelet trace amine profiles in migraine with and without aura. Cephalalgia 26(8):968–972PubMedCrossRef D’Andrea G, Granella F, Leone M, Perini F, Carruggio A, Bussone G (2006) Abnormal platelet trace amine profiles in migraine with and without aura. Cephalalgia 26(8):968–972PubMedCrossRef
8.
Zurück zum Zitat Stamatakis EA, Hetherington MM (2003) Neuroimaging in eating disorders. Nutritional Neuroscience 6(6):325–334PubMedCrossRef Stamatakis EA, Hetherington MM (2003) Neuroimaging in eating disorders. Nutritional Neuroscience 6(6):325–334PubMedCrossRef
9.
Zurück zum Zitat (1994) Diagnostic and statistical manual of mental disorders, 4th edn. text rev. American psychiatric Press, Washington DC (1994) Diagnostic and statistical manual of mental disorders, 4th edn. text rev. American psychiatric Press, Washington DC
10.
Zurück zum Zitat D’Andrea G, Terrazzino S, Fortin D, Farruggio A, Rinaldi L, Leon A (2003) HPLC electrochemical detection of trace amines in human plasma and platelets and expression on mRNA transcripts of trace amines receptors in circulating leukocites. Neurosci Lett 346:89–92PubMedCrossRef D’Andrea G, Terrazzino S, Fortin D, Farruggio A, Rinaldi L, Leon A (2003) HPLC electrochemical detection of trace amines in human plasma and platelets and expression on mRNA transcripts of trace amines receptors in circulating leukocites. Neurosci Lett 346:89–92PubMedCrossRef
11.
Zurück zum Zitat The International Classification of Headache Disorders (2004) Cephalalgia, 2nd edn. 24 (Suppl 1):1–160 The International Classification of Headache Disorders (2004) Cephalalgia, 2nd edn. 24 (Suppl 1):1–160
12.
Zurück zum Zitat Rasmussen KB (2006) Epidemiology of migraine. In: Olesen J, Goasby PJ, Ramadan MN, Tfelt-Hansen P, Welch KMA (eds) The headache 3rd edn Lippincott Williams&Wilkins, pp 235–242 Rasmussen KB (2006) Epidemiology of migraine. In: Olesen J, Goasby PJ, Ramadan MN, Tfelt-Hansen P, Welch KMA (eds) The headache 3rd edn Lippincott Williams&Wilkins, pp 235–242
13.
Zurück zum Zitat Ostuzzi R, D’Andrea G, Francesconi F, Musco F (2008) Eating disorders and headache: coincidence or consequences? Neurol Sci 29:S83–S87PubMedCrossRef Ostuzzi R, D’Andrea G, Francesconi F, Musco F (2008) Eating disorders and headache: coincidence or consequences? Neurol Sci 29:S83–S87PubMedCrossRef
14.
Zurück zum Zitat D’Andrea G, Nordera GP, Perini F, Allais G, Granella F (2007) Biochemistry of neuromodulation in primary headaches: focus on tyrosine metabolism. Neurol Sci 28:S1–S5CrossRef D’Andrea G, Nordera GP, Perini F, Allais G, Granella F (2007) Biochemistry of neuromodulation in primary headaches: focus on tyrosine metabolism. Neurol Sci 28:S1–S5CrossRef
15.
Zurück zum Zitat D’Andrea G, Terrazzino S, Fortin D, Cocco P, Balbi T (2003) Elusive amines and primary headaches: historical background and prospectives. Neurol Sci 24:S65–S67PubMed D’Andrea G, Terrazzino S, Fortin D, Cocco P, Balbi T (2003) Elusive amines and primary headaches: historical background and prospectives. Neurol Sci 24:S65–S67PubMed
16.
Zurück zum Zitat D’Andrea G, Terrazzino S, Leon A, Fortin D, Perini F, Granella F, Bussone G (2004) Elevated levels of circulating trace amines in primary headaches. Neurology 62:1701–1705PubMedCrossRef D’Andrea G, Terrazzino S, Leon A, Fortin D, Perini F, Granella F, Bussone G (2004) Elevated levels of circulating trace amines in primary headaches. Neurology 62:1701–1705PubMedCrossRef
17.
Zurück zum Zitat Carpenè C, Galitzky J, Fontana E, Lafontan M, Atgié C, AtgiéC Lafontan M, Berlan M et al (1999) Selective activation of Β3-adrenoceptors by octopamine: comparative studies in mammalian cells. Naunyn-Schmiedeberg’s Arch Pharmacol 359:310–321CrossRef Carpenè C, Galitzky J, Fontana E, Lafontan M, Atgié C, AtgiéC Lafontan M, Berlan M et al (1999) Selective activation of Β3-adrenoceptors by octopamine: comparative studies in mammalian cells. Naunyn-Schmiedeberg’s Arch Pharmacol 359:310–321CrossRef
18.
Zurück zum Zitat Visintin V, Morin N, Fontana E, Prevot D, Boucher J, Castan I, Valet P, Grujic D, Carpenè C (2001) Dual action of octopamine on glucose transport into adipocites: inhibition via Β3-adrenoceptor activation and stimulation via oxidation by amine oxidases. JPET 299:96–104 Visintin V, Morin N, Fontana E, Prevot D, Boucher J, Castan I, Valet P, Grujic D, Carpenè C (2001) Dual action of octopamine on glucose transport into adipocites: inhibition via Β3-adrenoceptor activation and stimulation via oxidation by amine oxidases. JPET 299:96–104
19.
Zurück zum Zitat Uher R, Brammer MJ, Murphy T, Campbell CI, Ng VW, Williams S, Treasure J (2003) Recovery and chronicity in anorexia nervosa: brain activity associated with differential outcomes. Biol Psychiatry 54:934–942PubMedCrossRef Uher R, Brammer MJ, Murphy T, Campbell CI, Ng VW, Williams S, Treasure J (2003) Recovery and chronicity in anorexia nervosa: brain activity associated with differential outcomes. Biol Psychiatry 54:934–942PubMedCrossRef
20.
Zurück zum Zitat Seeger G, Braus DF, Ruf M, Golderberg U, Schmidt MH (2002) Body image distortion reveals amygdala activaton in patients with anorexia nervosa-a functional magnetic resonance imaging study. Neurosci Lett 326:25–28PubMedCrossRef Seeger G, Braus DF, Ruf M, Golderberg U, Schmidt MH (2002) Body image distortion reveals amygdala activaton in patients with anorexia nervosa-a functional magnetic resonance imaging study. Neurosci Lett 326:25–28PubMedCrossRef
21.
Zurück zum Zitat Uher R, Murphy T, Brammer MJ, Dalgeish T, Phillips ML et al (2004) Medial prefrontal cortex activity associated with symptoms provocation in eating disorders. Am J Psychiatry 161:1238–1246PubMedCrossRef Uher R, Murphy T, Brammer MJ, Dalgeish T, Phillips ML et al (2004) Medial prefrontal cortex activity associated with symptoms provocation in eating disorders. Am J Psychiatry 161:1238–1246PubMedCrossRef
22.
Zurück zum Zitat Borowsky B, Adham N, Jones KA et al (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98:933–941CrossRef Borowsky B, Adham N, Jones KA et al (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98:933–941CrossRef
23.
Zurück zum Zitat Jordan J, Joice PR, Carter FA, Horn L et al (2008) Specific and nonspecific comorbidity in anorexia nervosa. Int J Eat Disord 41(19):47–56PubMedCrossRef Jordan J, Joice PR, Carter FA, Horn L et al (2008) Specific and nonspecific comorbidity in anorexia nervosa. Int J Eat Disord 41(19):47–56PubMedCrossRef
24.
Zurück zum Zitat D’Andrea G, Granella F, Perini F, Farruggio A, Leone M, Bussone G (2006) Platelet levels of dopamine are increased in migraine and cluster headache. Headache 46:585–591PubMedCrossRef D’Andrea G, Granella F, Perini F, Farruggio A, Leone M, Bussone G (2006) Platelet levels of dopamine are increased in migraine and cluster headache. Headache 46:585–591PubMedCrossRef
25.
Zurück zum Zitat Fernandez F, Lea RA, Colson NJ, Bellis C, Quinlan S, Griffiths CR (2006) Association between a 19 bp deletion polymorphism at the dopamine β-hydroxylase (DBH) locus and migraine with aura. J Neurol Sci 21 251(1–2):118–123CrossRef Fernandez F, Lea RA, Colson NJ, Bellis C, Quinlan S, Griffiths CR (2006) Association between a 19 bp deletion polymorphism at the dopamine β-hydroxylase (DBH) locus and migraine with aura. J Neurol Sci 21 251(1–2):118–123CrossRef
26.
Zurück zum Zitat D’Andrea G, D’Arrigo A, Dalle Cabonare M, Leon A (2012) Pathogenesis of migraine: role of neuromodulators. Headache (in press) D’Andrea G, D’Arrigo A, Dalle Cabonare M, Leon A (2012) Pathogenesis of migraine: role of neuromodulators. Headache (in press)
27.
Zurück zum Zitat Demarquay G, Royet JP, Mick G, Ryvlin P (2008) Olfactory hypersensitivity in migraineurs: a H (2) (15) O-PET study. Cephalalgia 28(10):1069–1080PubMedCrossRef Demarquay G, Royet JP, Mick G, Ryvlin P (2008) Olfactory hypersensitivity in migraineurs: a H (2) (15) O-PET study. Cephalalgia 28(10):1069–1080PubMedCrossRef
Metadaten
Titel
Is migraine a risk factor for the occurrence of eating disorders? Prevalence and biochemical evidences
verfasst von
Giovanni D’Andrea
Roberto Ostuzzi
Andrea Bolner
Davide Colavito
Alberta Leon
Publikationsdatum
01.05.2012
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe Sonderheft 1/2012
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-1045-6

Weitere Artikel der Sonderheft 1/2012

Neurological Sciences 1/2012 Zur Ausgabe

A REDEFINITION OF PRIMARY HEADACHES

A redefinition of primary headache: chronic migraine

Posters

Posters

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.